Celularity (CELU) Operating Leases (2022 - 2025)
Celularity (CELU) posted quarterly Operating Leases of $26.9 million for Q4 2025, up 1.32% year-over-year from $26.5 million in Q4 2024, and little changed quarter-over-quarter from $26.8 million in Q3 2025.
Celularity (CELU) Operating Leases (2022 - 2025) Analysis & Trends
Celularity (CELU) has reported Operating Leases for 4 consecutive years, with $26.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases rose 1.32% year-over-year to $26.9 million; the TTM figure through Dec 2025 stood at $26.9 million (up 1.32% YoY), while the FY2025 annual figure was $26.9 million, up 1.32% from the prior year.
- Operating Leases held at $26.9 million in Q4 2025 per CELU's latest filing, from $26.8 million in the prior quarter.
- Across five years, Operating Leases topped out at $30.5 million in Q1 2022 and bottomed at $26.1 million in Q3 2023.
- Historically, Operating Leases has averaged $27.2 million across 4 years, with a median of $26.8 million in 2025.
- Annual changes were most pronounced in 2023 — Operating Leases slipped 7.92% — and 2024, when it advanced 1.45%.
- Celularity's Operating Leases stood at $28.0 million in 2022, then retreated by 6.46% to $26.2 million in 2023, then advanced by 1.42% to $26.5 million in 2024, then gained by 1.32% to $26.9 million in 2025.
- Business Quant data shows CELU's Operating Leases at $26.9 million in Q4 2025, $26.8 million in Q3 2025, and $26.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - |
| 10 | Celularity | 19.68 Mn | 13.50 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.90 Mn |
| Sep 30, 2025 | 26.81 Mn |
| Jun 30, 2025 | 26.72 Mn |
| Mar 31, 2025 | 26.63 Mn |
| Dec 31, 2024 | 26.55 Mn |
| Sep 30, 2024 | 26.45 Mn |
| Jun 30, 2024 | 26.36 Mn |
| Mar 31, 2024 | 26.27 Mn |
| Dec 31, 2023 | 26.18 Mn |
| Sep 30, 2023 | 26.07 Mn |
| Jun 30, 2023 | 28.10 Mn |
| Mar 31, 2023 | 28.05 Mn |
| Dec 31, 2022 | 27.99 Mn |
| Sep 30, 2022 | 27.92 Mn |
| Jun 30, 2022 | 27.85 Mn |
| Mar 31, 2022 | 30.46 Mn |